Anthem Blue Cross (HMO, PPO, EPO)
Kanuma (sebelipase alfa)
Drugs for Metabolic Disease : Drugs for Metabolic Disease
  • Step Therapy: Diabetes Type 2: GLP1 + Combo:
    ST Single Generic

  • Prior Authorization: Bone Loss Treatments:
    Documented Diagnosis: Yes
    Duration: 1 year(s)

  • Breast Cancer: HR+ (HER2-):
    Duration: 12 Month(s)
    Specialist Required: Yes

    Breast Cancer: HR+ (HER2+):
    Duration: 12 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): Oncologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

<< Return | Back to top